Skip to content

Evaluation of a New Daily Disposable Multifocal Contact Lens Design

Delefilcon A Multifocal Plus Power Lens Design Evaluation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01951573
Enrollment
36
Registered
2013-09-26
Start date
2013-10-31
Completion date
2013-11-30
Last updated
2014-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperopia, Presbyopia, Refractive Error

Keywords

contact lenses, multifocal, daily disposable, silicone hydrogel, presbyopia

Brief summary

The purpose of this study is to demonstrate non-inferiority of a new daily disposable multifocal contact lens in plus powers against the commercially available AIR OPTIX® AQUA MULTIFOCAL (AOAMF) lens in high contrast/high illumination (HC/HI) near visual acuity (VA).

Interventions

Silicone hydrogel multifocal contact lenses for daily wear, daily disposable use

Silicone hydrogel multifocal contact lenses with a labeled indication for daily wear and extended wear use of up to 6 days with monthly replacement

Sponsors

Alcon Research
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subjects with normal eyes who are not using any ocular medication. * Must sign the Informed Consent document. * Habitual lens power within the range available for the study lenses (+1.00 to +3.50 diopters(D)). * Manifest cylinder less than or equal to 0.75D. * Best corrected distance VA greater than or equal to 20/25 in each eye. * Existing soft contact lens (CL) wearers who wear contact lenses in both eyes at least 5 days per week. * Presbyopic with a spectacle addition (ADD) \>0.50D and \<2.75D. * Other protocol-defined inclusion criteria may apply.

Exclusion criteria

* Any ocular disease, inflammation, or abnormality that contraindicates CL wear. * Any use of systemic or ocular medications for which CL wear could be contraindicated. * History of herpetic keratitis. * History of refractive surgery or irregular cornea. * A clinically significant dry eye that precludes CL wear. * Participation of the subject in a clinical study (including CL or CL care product) within the previous 30 days. * Monocular (only 1 eye with functional vision). * History of intolerance or hypersensitivity to any component of the test articles. * Other protocol-defined

Design outcomes

Primary

MeasureTime frameDescription
High Contrast/High Illumination (HC/HI) Binocular Visual Acuity (VA) at NearDispense (Day 1), Hour 9Near VA was assessed binocularly (both eyes together) at 40 centimeters, with over-refraction (OR), if necessary, and measured in logMAR units (logarithm of the minimum angle of resolution). A logMAR acuity of 0.0 corresponds to 20/20 Snellen acuity, with a negative value denoting better than 20/20 visual acuity.

Secondary

MeasureTime frameDescription
HC/HI Binocular VA at DistanceDispense (Day 1), Hour 9Distance VA was assessed binocularly (both eyes together) at 6 meters, with over-refraction (OR), if necessary, and measured in logMAR units (logarithm of the minimum angle of resolution). A logMAR acuity of 0.0 corresponds to 20/20 Snellen acuity, with a negative value denoting better than 20/20 visual acuity.
Over-refraction (OR) Monocular at DistanceDispense (Day 1), Hour 9OR (the amount of additional correction needed to improve VA) at distance (equivalent to 6 meters) was assessed monocularly (for each eye separately) in diopters (D). Both eyes contributed to the mean.

Participant flow

Recruitment details

Subjects were recruited from 1 study center located in the US.

Pre-assignment details

Of the 36 enrolled, 2 subjects were exited as screen failures prior to randomization. This reporting group includes all randomized subjects (34).

Participants by arm

ArmCount
Overall
Delefilcon A MF and AOAMF contact lenses worn during Period 1 and Period 2 in a crossover assignment.
34
Total34

Withdrawals & dropouts

PeriodReasonFG000FG001
Washout PeriodAdverse Event01

Baseline characteristics

CharacteristicOverall
Age, Continuous59.9 years
STANDARD_DEVIATION 8.2
Sex: Female, Male
Female
30 Participants
Sex: Female, Male
Male
4 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 330 / 34
serious
Total, serious adverse events
0 / 330 / 34

Outcome results

Primary

High Contrast/High Illumination (HC/HI) Binocular Visual Acuity (VA) at Near

Near VA was assessed binocularly (both eyes together) at 40 centimeters, with over-refraction (OR), if necessary, and measured in logMAR units (logarithm of the minimum angle of resolution). A logMAR acuity of 0.0 corresponds to 20/20 Snellen acuity, with a negative value denoting better than 20/20 visual acuity.

Time frame: Dispense (Day 1), Hour 9

Population: This analysis population includes all randomized subjects excluding those who met any of the specified deviation criteria.

ArmMeasureGroupValue (MEAN)Dispersion
Delefilcon A MFHigh Contrast/High Illumination (HC/HI) Binocular Visual Acuity (VA) at NearDispense0.10 logMARStandard Deviation 0.09
Delefilcon A MFHigh Contrast/High Illumination (HC/HI) Binocular Visual Acuity (VA) at NearHour 90.08 logMARStandard Deviation 0.09
AOAMFHigh Contrast/High Illumination (HC/HI) Binocular Visual Acuity (VA) at NearDispense0.12 logMARStandard Deviation 0.06
AOAMFHigh Contrast/High Illumination (HC/HI) Binocular Visual Acuity (VA) at NearHour 90.09 logMARStandard Deviation 0.07
Secondary

HC/HI Binocular VA at Distance

Distance VA was assessed binocularly (both eyes together) at 6 meters, with over-refraction (OR), if necessary, and measured in logMAR units (logarithm of the minimum angle of resolution). A logMAR acuity of 0.0 corresponds to 20/20 Snellen acuity, with a negative value denoting better than 20/20 visual acuity.

Time frame: Dispense (Day 1), Hour 9

Population: This analysis population includes all randomized subjects excluding those who met any of the specified deviation criteria.

ArmMeasureGroupValue (MEAN)Dispersion
Delefilcon A MFHC/HI Binocular VA at DistanceDispense-0.02 logMARStandard Deviation 0.06
Delefilcon A MFHC/HI Binocular VA at DistanceHour 90.00 logMARStandard Deviation 0.07
AOAMFHC/HI Binocular VA at DistanceDispense-0.03 logMARStandard Deviation 0.06
AOAMFHC/HI Binocular VA at DistanceHour 9-0.01 logMARStandard Deviation 0.07
Secondary

Over-refraction (OR) Monocular at Distance

OR (the amount of additional correction needed to improve VA) at distance (equivalent to 6 meters) was assessed monocularly (for each eye separately) in diopters (D). Both eyes contributed to the mean.

Time frame: Dispense (Day 1), Hour 9

Population: This analysis population includes all randomized subjects excluding those who met any of the specified deviation criteria.

ArmMeasureGroupValue (MEAN)Dispersion
Delefilcon A MFOver-refraction (OR) Monocular at DistanceDispense0.00 DioptersStandard Deviation 0
Delefilcon A MFOver-refraction (OR) Monocular at DistanceHour 90.11 DioptersStandard Deviation 0.16
AOAMFOver-refraction (OR) Monocular at DistanceDispense0.00 DioptersStandard Deviation 0
AOAMFOver-refraction (OR) Monocular at DistanceHour 90.09 DioptersStandard Deviation 0.14

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026